LICENSE AGREEMENTLicense Agreement • February 13th, 2023 • Forian Inc. • Services-computer processing & data preparation • Delaware
THIS LICENSE AGREEMENT (this “Agreement”), dated as of February 10, 2023 (the “Effective Date”), is made and entered into by and among Forian Inc., a Delaware corporation (“Forian”) and Helix Technologies, Inc., a Delaware Corporation (“Seller” and together with Forian, the “Licensees”), each for itself and for the benefit of their respective Affiliates, collectively as licensees, on the one hand, and each of BT Assets Group, Inc., a Delaware corporation (“Buyer”), and Bio-Tech Medical Software, Inc., a Florida corporation (the “Company”), each for itself and on behalf of their respective Affiliates, collectively as licensors, on the other hand. Buyer and the Company are referred to in this Agreement each as a “Licensor” and collectively as the “Licensors”. Forian, Seller, Buyer and the Company are collectively referred to in this Agreement each as a “Party” and collectively as the “Parties.”
STOCK PURCHASE AGREEMENT BY AND AMONG BIO-TECH MEDICAL SOFTWARE, INC., HELIX TECHNOLOGIES, INC. AND BT ASSETS GROUP, INC. DATED AS OF FEBRUARY 10, 2023Stock Purchase Agreement • February 13th, 2023 • Forian Inc. • Services-computer processing & data preparation • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of February 10, 2023, by and among BT Assets Group, Inc., a Delaware corporation (“Buyer”), on the one hand, and each of Helix Technologies, Inc., a Delaware corporation (“Seller”), and Bio-Tech Medical Software, Inc. (d/b/a BioTrack), a Florida corporation and a wholly owned subsidiary of Seller (the “Company”), on the other hand.
Re: Separation and Release AgreementForian Inc. • February 13th, 2023 • Services-computer processing & data preparation • Pennsylvania
With our sincere thanks for your service to Forian Inc. (together with its subsidiary and affiliated companies, collectively the “Company”), this letter agreement (the “Agreement”) sets forth the terms and conditions of our mutual agreement regarding the separation of your employment as the Chief Executive Officer and President of the Company consistent with your rights and obligations as set forth in that certain Employment Agreement, dated as of October 16, 2019, by and between you and the Company (through its subsidiary, Medical Outcomes Research Analytics, LLC)(the “Employment Agreement”). Capitalized terms used and not defined herein shall have the meanings given to such terms in that certain Employment Agreement.
